This bill, titled the "Safeguarding Testing and Overdose Prevention Against Fentanyl and Xylazine Act" or "STOP Fentanyl and Xylazine Act," seeks to amend the Controlled Substances Act. Specifically, it proposes to clarify Section 422 (21 U.S.C. 863) of the Act, which generally prohibits drug paraphernalia. The amendment adds a new subsection (g) to explicitly state that this section does not apply to equipment intended to indicate the presence of fentanyl or xylazine in a compound. This clarification covers the possession, sale, purchase, importation, exportation, or transportation of such drug testing equipment. The overall goal is to ensure that tools designed to detect these potent substances are not considered unlawful under federal law.